James Harvey, MD
Interventional Cardiology · Chambersburg, PANPI 1417969536
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $294,069 of the $442,025 with a category attached, or 66.5%. Medtronic accounts for 67.2% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $134,458 and has fallen 96.3% since, to $4,949 in 2025. Among interventional cardiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 607 payments — averaging $728.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$297K
- Boston Scientific$65K
- Baylis Medical Company Inc$31K
- Abiomed$29K
- Edwards Lifesciences$7K
- Opsens Inc.$7K
- plus $7K from 26 others
Across 201 payments — averaging $3092.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$289K
- Medtronic$149K
- Edwards Lifesciences$148K
- Bard Peripheral Vascular, Inc.$35K
- C. R. Bard, Inc. & Subsidiaries$750
What the payments were for
- Consulting fees$73,75017%
- Speaking & faculty fees$294,06967%
- Travel & lodging$58,75013%
- Food & beverage$15,2123%
- Education$210%
- Entertainment$2240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 358 | $297,031 |
| Boston Scientific | 109 | $64,666 |
| Baylis Medical Company Inc | 5 | $31,000 |
| Abiomed | 29 | $28,598 |
| Edwards Lifesciences | 36 | $6,863 |
| Opsens Inc. | 9 | $6,790 |
| Canon Medical Systems USA, Inc. | 1 | $2,500 |
| Abbott | 17 | $1,914 |
| Siemens Medical Solutions USA, Inc. | 6 | $1,033 |
| Johnson & Johnson | 5 | $298 |
| Biosense Webster, Inc. | 4 | $198 |
| Cardiovascular Systems Inc. | 2 | $166 |
| Intuitive Surgical | 1 | $133 |
| Asahi Intecc USA, Inc. | 1 | $117 |
| Amgen | 1 | $100 |
| Biotronik Inc. | 2 | $100 |
| Shockwave Medical, Inc | 2 | $80 |
| Terumo Medical Corporation | 1 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $53 |
| Inari Medical, Inc. | 2 | $37 |
| Centerline Biomedical Inc. | 1 | $36 |
| GE HealthCare | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Philips North America LLC | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| Stryker | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| BD | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$189,657
- COREVALVE EVOLUT R$97,513
- VersaCross Access Solution$46,000
- Impella$28,313
- GENERAL VASCULAR ACCESS$16,025
- GENERAL - THERAPIES$11,903
- GENERAL - STRUCTURAL HEART$9,113
- SavvyWire$5,400
- Edwards SAPIEN 3 Transcatheter Heart Valve$3,718
- Resolute$3,106
- CROSSBOSS$3,000
- Watchman$2,509
- VASCULAR$2,500
- EVOQUE$1,533
- TRICLIP$1,125
- STINGRAY$1,121
- NAEOTOM Alpha$835
- OptoWire$727
- OptoMonitor$500
- In development$500
How this compares
$442,025 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $291 |
| Ezetimibe | 12 | $228 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Chambersburg
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1M
- William GrayWynnewood$753K
- Jon GeorgePhiladelphia$637K
- Shailendra SinghAllentown$470K
- Sanjog KalraPhiladelphia$444K
- Taisei KobayashiPhiladelphia$384K
- Antonis PratsosBroomall$377K
- Ronald FieldsNew Hope$373K
- David LasordaPittsburgh$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.